177 related articles for article (PubMed ID: 18276852)
1. Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.
George DT; Gilman J; Hersh J; Thorsell A; Herion D; Geyer C; Peng X; Kielbasa W; Rawlings R; Brandt JE; Gehlert DR; Tauscher JT; Hunt SP; Hommer D; Heilig M
Science; 2008 Mar; 319(5869):1536-9. PubMed ID: 18276852
[TBL] [Abstract][Full Text] [Related]
2. [A new pharmacological treatment option for alcohol dependence discovered in transnational study: neurokinin-1 receptor antagonist as a possible therapy for alcoholism?].
Mutschler J; Grosshans M; Kiefer F
Neuropsychiatr; 2008; 22(4):283-5. PubMed ID: 19081000
[TBL] [Abstract][Full Text] [Related]
3. Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder.
Tauscher J; Kielbasa W; Iyengar S; Vandenhende F; Peng X; Mozley D; Gehlert DR; Marek G
Eur Neuropsychopharmacol; 2010 Feb; 20(2):80-7. PubMed ID: 20018493
[TBL] [Abstract][Full Text] [Related]
4. Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist.
Huang H; Zhang X; Fu X; Zhang X; Lang B; Xiang X; Hao W
Psychopharmacology (Berl); 2018 Oct; 235(10):2847-2857. PubMed ID: 30054674
[TBL] [Abstract][Full Text] [Related]
5. Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice.
Thorsell A; Schank JR; Singley E; Hunt SP; Heilig M
Psychopharmacology (Berl); 2010 Mar; 209(1):103-11. PubMed ID: 20112009
[TBL] [Abstract][Full Text] [Related]
6. Artificial microRNA-based neurokinin-1 receptor gene silencing reduces alcohol consumption in mice.
Baek MN; Jung KH; Halder D; Choi MR; Lee BH; Lee BC; Jung MH; Choi IG; Chung MK; Oh DY; Chai YG
Neurosci Lett; 2010 May; 475(3):124-8. PubMed ID: 20347940
[TBL] [Abstract][Full Text] [Related]
7. Psychopharmacology. Tackling alcoholism with drugs.
Miller G
Science; 2008 Apr; 320(5873):168-70. PubMed ID: 18403685
[No Abstract] [Full Text] [Related]
8. Neurokinin receptors in drug and alcohol addiction.
Schank JR
Brain Res; 2020 May; 1734():146729. PubMed ID: 32067964
[TBL] [Abstract][Full Text] [Related]
9. The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study.
Kwako LE; George DT; Schwandt ML; Spagnolo PA; Momenan R; Hommer DW; Diamond CA; Sinha R; Shaham Y; Heilig M
Psychopharmacology (Berl); 2015 Jan; 232(1):295-304. PubMed ID: 25030801
[TBL] [Abstract][Full Text] [Related]
10. Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats.
Schank JR; Tapocik JD; Barbier E; Damadzic R; Eskay RL; Sun H; Rowe KE; King CE; Yao M; Flanigan ME; Solomon MG; Karlsson C; Cheng K; Rice KC; Heilig M
Biol Psychiatry; 2013 Apr; 73(8):774-81. PubMed ID: 23419547
[TBL] [Abstract][Full Text] [Related]
11. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study.
Kwako LE; Spagnolo PA; Schwandt ML; Thorsell A; George DT; Momenan R; Rio DE; Huestis M; Anizan S; Concheiro M; Sinha R; Heilig M
Neuropsychopharmacology; 2015 Mar; 40(5):1053-63. PubMed ID: 25409596
[TBL] [Abstract][Full Text] [Related]
12. In vitro and ex vivo autoradiography of the NK-1 antagonist [³H]-LY686017 in Guinea pig brain.
Gackenheimer SL; Gehlert DR
Neuropeptides; 2011 Apr; 45(2):157-64. PubMed ID: 21295853
[TBL] [Abstract][Full Text] [Related]
13. Findings on alcohol dependence point to promising avenues for targeted therapies.
Kuehn BM
JAMA; 2009 Apr; 301(16):1643-5. PubMed ID: 19383946
[No Abstract] [Full Text] [Related]
14. The neurokinin-1 receptor in addictive processes.
Schank JR
J Pharmacol Exp Ther; 2014 Oct; 351(1):2-8. PubMed ID: 25038175
[TBL] [Abstract][Full Text] [Related]
15. The neurokinin-1 receptor mediates escalated alcohol intake induced by multiple drinking models.
Sequeira MK; Nelson BS; Fulenwider HD; King CE; Nennig SE; Bohannon JB; Cheng K; Rice KC; Heilig M; Schank JR
Neuropharmacology; 2018 Jul; 137():194-201. PubMed ID: 29758386
[TBL] [Abstract][Full Text] [Related]
16. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
[TBL] [Abstract][Full Text] [Related]
17. The effects of lipopolysaccharide exposure on social interaction, cytokine expression, and alcohol consumption in male and female mice.
Decker Ramirez EB; Arnold ME; McConnell KT; Solomon MG; Amico KN; Schank JR
Physiol Behav; 2023 Jun; 265():114159. PubMed ID: 36931488
[TBL] [Abstract][Full Text] [Related]
18. The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.
Paterson LM; Flechais RS; Murphy A; Reed LJ; Abbott S; Boyapati V; Elliott R; Erritzoe D; Ersche KD; Faluyi Y; Faravelli L; Fernandez-Egea E; Kalk NJ; Kuchibatla SS; McGonigle J; Metastasio A; Mick I; Nestor L; Orban C; Passetti F; Rabiner EA; Smith DG; Suckling J; Tait R; Taylor EM; Waldman AD; Robbins TW; Deakin JF; Nutt DJ; Lingford-Hughes AR;
J Psychopharmacol; 2015 Sep; 29(9):943-60. PubMed ID: 26246443
[TBL] [Abstract][Full Text] [Related]
19. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
20. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
